Cadmium toxicity alleviation through exogenous application of gibberellic acid (GA3) in mustard (Brassica juncea (L.) czern.) and rapeseed (Brassica rapa L.)

An experiment was carried out by considering adverse impact of heavy metals on human health through consumption of crops. To alleviate the adverse effects of cadmium (Cd) toxicity through foliar application of gibberellic acid (GA3), two varieties of Brassica including Indian mustard (Brassica juncea (L.) Czern.) commonly known as ‘Raya’ and rapeseed (Brassica rapa L.) as ‘Toria’ were studied. The Completely Randomized Design (CRD) was used with eight treatments including control in four replicates. Treatments were as following, T0 (control), T1 (150 μM CdCl2), T2 (50 mg/L GA3), T3 (75 mg/L GA3), T4 (100 mg/L GA3), T5 (150 μM CdCl2 + 50 mg/L GA3), T6 (150 μM CdCl2 + 75 mg/L GA3), and T7 (150 μM CdCl2 + 100 mg/L GA3). Gibberellic acid (GA3), a plant growth regulator applied exogenously. The concentration of cadmium (150 μM CdCl2) resulted in Cd toxicity affected adversely the morphological and biochemical parameters. Foliar application of GA3 (50 mg, 75 mg and 100 mg) positively influenced the various growth parameters as root length (30 cm), shoot length (129.75 cm), number of leaves (14.5), pods per plant (88) and biochemical parameters like total chlorophyll (0.19 mg/g), protein content (0.70 mg/mL), carbohydrates (0.37 mg/mL) and CAT (0.56 units/mg). Outcome indicated that GA3 reduces the harmful effects of Cd stress in both varieties. It was concluded that all growth and yield parameters of variety ‘Raya’ were better as compared to variety ‘Toria’, hence Raya recommended for large scale cultivation with GA3 under Cd stress

Burnout among surgeons before and during the SARS-CoV-2 pandemic: an international survey

Background: SARS-CoV-2 pandemic has had many significant impacts within the surgical realm, and surgeons have been obligated to reconsider almost every aspect of daily clinical practice. Methods: This is a cross-sectional study reported in compliance with the CHERRIES guidelines and conducted through an online platform from June 14th to July 15th, 2020. The primary outcome was the burden of burnout during the pandemic indicated by the validated Shirom-Melamed Burnout Measure. Results: Nine hundred fifty-four surgeons completed the survey. The median length of practice was 10 years; 78.2% included were male with a median age of 37 years old, 39.5% were consultants, 68.9% were general surgeons, and 55.7% were affiliated with an academic institution. Overall, there was a significant increase in the mean burnout score during the pandemic; longer years of practice and older age were significantly associated with less burnout. There were significant reductions in the median number of outpatient visits, operated cases, on-call hours, emergency visits, and research work, so, 48.2% of respondents felt that the training resources were insufficient. The majority (81.3%) of respondents reported that their hospitals were included in the management of COVID-19, 66.5% felt their roles had been minimized; 41% were asked to assist in non-surgical medical practices, and 37.6% of respondents were included in COVID-19 management. Conclusions: There was a significant burnout among trainees. Almost all aspects of clinical and research activities were affected with a significant reduction in the volume of research, outpatient clinic visits, surgical procedures, on-call hours, and emergency cases hindering the training. Trial registration: The study was registered on clicaltrials.gov "NCT04433286" on 16/06/2020